Stock comparison
BOSTON SCIENTIFIC CORP is 19.6x more valuable than HAEMONETICS CORP by market capitalization ($66.87 B vs $3.41 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BSX is larger
BOSTON SCIENTIFIC CORP is 19.6x more valuable than HAEMONETICS CORP by market capitalization ($66.87 B vs $3.41 B).
Market value leader
BSX
BOSTON SCIENTIFIC CORP is 19.6x more valuable than HAEMONETICS CORP by market capitalization ($66.87 B vs $3.41 B).
Revenue leader
BSX
HAE: $1.33B vs BSX: $20.07B.
| Metric | HAE | BSX |
|---|---|---|
| Market cap | $3.41 B | $66.87 B |
| US-listed rank | #1725 | #256 |
| Revenue (latest FY) | $1.33B | $20.07B |
| Net income (latest FY) | $97.31M | - |
| Net margin | 7.3% | - |
| P/E (trailing FY) | 35.0x | - |
| SEC filings | 1,875 | 1,009 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BOSTON SCIENTIFIC CORP is 19.6x more valuable than HAEMONETICS CORP by market capitalization ($66.87 B vs $3.41 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: HAEMONETICS CORP and BOSTON SCIENTIFIC CORP, or browse the full rankings.